BIA is proud to announce Muscular Dystrophy UK as its charity partner for 2026.
More than 110,000 people in the UK live with a muscle-wasting condition, which gradually affects the way their muscles work, limiting everyday activities and, in some cases, shortening lives.
There are over 60 different muscle-wasting conditions, many of which are rare and often misunderstood.
Through this partnership, the BIA aims to raise awareness of these conditions, highlight the need for timely access to new treatments and support, and advocate for improvements in the speed, accuracy, and equity of diagnosis. Over the next 12 months, the BIA will support Muscular Dystrophy UK through strategic initiatives and fundraising activities, leveraging its network within the UK life sciences and biotech sector.
The partnership will be formally launched at the BIA Gala Dinner on Thursday, 29 January 2026, at the Roundhouse in Camden, London, celebrating the collaboration and its potential impact for those affected by muscle-wasting conditions.